Glucosamine induces cell death via proteasome inhibition in human ALVA41 prostate cancer cell

Experimental and Molecular Medicine

Volumn 43, Issue 9, 2011, Pages 487-493

  Liu, Bao Qin ^a   Meng, Xin ^a   Li, Chao ^a   Gao, Yan Yan ^a   Li, Ning ^a   Niu, Xiao Fang ^a   Guan, Yifu ^a   Wang, Hua Qin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Glucosamine; Glycosylation; Ki antigen; Prostatic neoplasms; Proteasome

Indexed keywords

GLUCOSAMINE; N ACETYLGLUCOSAMINE; PROTEASOME; PROTEIN PA28 ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL STRAIN ALVA41; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING;

EID: 80053223839     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2011.43.9.055     Document Type: Article

References (32)

1. Adams J. The proteasome: a suitable antineoplastic target. Nat Rev Cancer 2004;4:349-60
2. Anderson JW, Nicolosi RJ, Borzelleca JF. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol 2005;43:187-201
3. Ball HA, Wick AN, Sanders C. Influence of glucose antimetabolites on the Walker tumor. Cancer Res 1957; 17:235-9
4. Biggee BA, McAlindon T. Glucosamine for osteoarthritis: part II, biologic and metabolic controversies. Med Health R I 2004;87:180-1
5. Dong DL, Hart GW. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. J Biol Chem 1994;269:19321-30
6. Fjelde A, Sorkin E, Rhodes JM. The effect of glucosamine on human epidermoid carcinoma cells in tissue culture. Exp Cell Res 1956;10:88-98
7. Hagemann C, Patel R, Blank JL. MEKK3 interacts with the PA28 gamma regulatory subunit of the proteasome. Biochem J 2003;373:71-9
8. Han I, Kudlow JE. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol Cell Biol 1997;17:2550-8
9. Hart GW, Housley MP, Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 2007;446:1017-22
10. Kaleem A, Ahmad I, Hoessli DC, Walker-Nasir E, Saleem M, Shakoori AR, Nasir Ud D. Epidermal growth factor receptors: function modulation by phosphorylation and glycosylation interplay. Mol Biol Rep 2009;36:631-9
11. Kizer DE, Mc CT. The synthesis of hexosamine in tumor homogenates. Cancer Res 1959;19:307-10
12. Lee JH, Takahashi T, Yasuhara N, Inazawa J, Kamada S, Tsujimoto Y. Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death. Oncogene 1999;18:6183-90
13. Lingbeck JM, Trausch-Azar JS, Ciechanover A, Schwartz AL. In vivo interactions of MyoD, Id1, and E2A proteins determined by acceptor photobleaching fluorescence resonance energy transfer. FASEB J 2008;22:1694-701
14. Liu K, Paterson AJ, Zhang F, McAndrew J, Fukuchi K, Wyss JM, Peng L, Hu Y, Kudlow JE. Accumulation of protein O-GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O-GlcNAc metabolism. J Neurochem 2004;89:1044-55
15. Luhrs W. A contribution to the question glucosamine on the growth retardation of tumours. Acta Unio Int Contra Cancrum 1957;13:480-1
16. Marlow AA, Bartlett GR. Glucosamine and leukemia. Proc Soc Exp Biol Med 1953;84:41-3
17. Marshall S, Nadeau O, Yamasaki K. Dynamic actions of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes: differential effects on glucosamine 6-phosphate, UDP-N-acetylglucosamine, and ATP levels. J Biol Chem 2004;279:35313-9
18. Masson E, Wiernsperger N, Lagarde M, El Bawab S. Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides. Biochem J 2005;388:537-44
19. McClain DA. Hexosamines as mediators of nutrient sensing and regulation in diabetes. J Diabetes Complications 2002; 16:72-80
20. Murata S, Kawahara H, Tohma S, Yamamoto K, Kasahara M, Nabeshima Y, Tanaka K, Chiba T. Growth retardation in mice lacking the proteasome activator PA28gamma. J Biol Chem 1999;274:38211-5
21. Qian J, Steigerwald K, Combs KA, Barton MC, Groden J. Caspase cleavage of the APC tumor suppressor and release of an amino-terminal domain is required for the transcriptionindependent function of APC in apoptosis. Oncogene 2007; 26:4872-6
22. Quastel JH, Cantero A. Inhibition of tumour growth by D-glucosamine. Nature 1953;171:252-4
23. Rechsteiner M, Hill CP. Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol 2005;15:27-33
24. Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE, Gossett C. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001;357:251-6
25. Roessler M, Rollinger W, Mantovani-Endl L, Hagmann ML, Palme S, Berndt P, Engel AM, Pfeffer M, Karl J, Bodenmuller H, Ruschoff J, Henkel T, Rohr G, Rossol S, Rosch W, Langen H, Zolg W, Tacke M. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining twodimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol Cell Proteomics 2006;5:2092-101
26. Sorkin E, Fjelde A. The effect of D-glucosamine and related products on human cancer cells in tissue culture. G Ital Chemioter 1956;3:355-61
27. Su K, Yang X, Roos MD, Paterson AJ, Kudlow JE. Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1. Biochem J 2000;348 Pt 2:281-9
28. Tagawa Y, Hiramatsu N, Kasai A, Hayakawa K, Okamura M, Yao J, Kitamura M. Induction of apoptosis by cigarette smoke via ROS-dependent endoplasmic reticulum stress and CCAAT/enhancer-binding protein-homologous protein (CHOP). Free Radic Biol Med 2008;45:50-9
29. Thomas SM, Coppelli FM, Wells A, Gooding WE, Song J, Kassis J, Drenning SD, Grandis JR. Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma. Cancer Res 2003;63:5629-35
30. Zachara NE, O'Donnell N, Cheung WD, Mercer JJ, Marth JD, Hart GW. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem 2004;279:30133-42
31. Zhang F, Su K, Yang X, Bowe DB, Paterson AJ, Kudlow JE. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 2003;115:715-25
32. Zhang F, Hu Y, Huang P, Toleman CA, Paterson AJ, Kudlow JE. Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6. J Biol Chem 2007;282:22460-71